These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38529786)

  • 1. Regulatory Issues of Platform Trials: Learnings from EU-PEARL.
    Nguyen QL; Hees K; Hernandez Penna S; König F; Posch M; Bofill Roig M; Meyer EL; Freitag MM; Parke T; Otte M; Dauben HP; Mielke T; Spiertz C; Mesenbrink P; Gidh-Jain M; Pierre S; Morello S; Hofner B
    Clin Pharmacol Ther; 2024 Jul; 116(1):52-63. PubMed ID: 38529786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing generic templates to shape the future for conducting integrated research platform trials.
    Gidh-Jain M; Parke T; König F; Spiertz C; Mesenbrink P;
    Trials; 2024 Mar; 25(1):204. PubMed ID: 38515103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
    Barry E; Walsh JA; Weinrich SL; Beaupre D; Blasi E; Arenson DR; Jacobs IA
    Paediatr Drugs; 2021 Jul; 23(4):381-394. PubMed ID: 34173206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL.
    Koenig F; Spiertz C; Millar D; Rodríguez-Navarro S; Machín N; Van Dessel A; Genescà J; Pericàs JM; Posch M;
    EClinicalMedicine; 2024 Jan; 67():102384. PubMed ID: 38226342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.
    Neaton JD; Babiker A; Bohnhorst M; Darbyshire J; Denning E; Frishman A; Grarup J; Larson G; Lundgren J
    Clin Trials; 2010 Dec; 7(6):705-18. PubMed ID: 20729252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.
    Lombardo G; Couvert C; Kose M; Begum A; Spiertz C; Worrell C; Hasselbaink D; Didden EM; Sforzini L; Todorovic M; Lewi M; Brown M; Vaterkowski M; Gullet N; Amasi-Hartoonian N; Griffon N; Pais R; Rodriguez Navarro S; Kremer A; Maes C; Tan EH; Moinat M; Ferrer JG; Pariante CM; Kalra D; Ammour N; Kalko S
    J Biomed Inform; 2023 Dec; 148():104553. PubMed ID: 38000766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory issues with multiplicity in drug approval: Principles and controversies in a changing landscape.
    Benda N; Brandt A
    J Biopharm Stat; 2018; 28(1):3-9. PubMed ID: 29065277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development.
    Morant AV; Vestergaard HT; Lassen AB; Navikas V
    Clin Transl Sci; 2020 Jul; 13(4):652-664. PubMed ID: 32043310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory considerations for clinical development of cancer vaccines.
    Heelan BT
    Hum Vaccin Immunother; 2014; 10(11):3409-14. PubMed ID: 25625933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.
    Pericàs JM; Di Prospero NA; Anstee QM; Mesenbrinck P; Kjaer MS; Rivera-Esteban J; Koenig F; Sena E; Pais R; Manzano R; Genescà J; Tacke F; Ratziu V;
    Aliment Pharmacol Ther; 2023 May; 57(9):948-961. PubMed ID: 36918740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study.
    De Sutter E; Borry P; Huys I; Barbier L
    BMC Health Serv Res; 2023 Feb; 23(1):181. PubMed ID: 36810088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective.
    Ponzano S; Blake K; Bonelli M; Enzmann H;
    Clin Pharmacol Ther; 2018 Apr; 103(4):564-566. PubMed ID: 29105746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving drug regulatory landscape in China: A clinical pharmacology perspective.
    Tang W; Huang Y; Zhou D; Huang Y; Chen Y; Ren S; Li Y; Wu S; Zhao X; Song X; Wang H; Jin Y; Yu H; Zhang L; Li Y; Boulton D; Shen K
    Clin Transl Sci; 2021 Jul; 14(4):1222-1230. PubMed ID: 33503308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical considerations into the new EMA guideline on bioequivalence.
    Marzo A; Fontana E
    Arzneimittelforschung; 2011; 61(4):207-20. PubMed ID: 21650079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
    Ramirez I
    Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials.
    Klingmann I; Heckenberg A; Warner K; Haerry D; Hunter A; May M; See W
    Front Med (Lausanne); 2018; 5():251. PubMed ID: 30246010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.